<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="23" left="55" width="517" height="33" font="0"><b>ENCODE DCC Antibody Validation Document</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="77" left="138" width="78" height="12" font="1">September 5, 2011</text>
<text top="353" left="94" width="449" height="12" font="1">Monoclonal antibody is produced by immunizing rabbit with a synthetic peptide corresponding to residues </text>
<text top="365" left="94" width="162" height="12" font="1">surrounding Leu330 of human TCF7L2.</text>
<text top="485" left="150" width="31" height="12" font="1">Human</text>
<text top="521" left="178" width="89" height="12" font="2">Immunoprecipitation</text>
<text top="134" left="326" width="66" height="12" font="1">frietze@usc.edu</text>
<text top="134" left="83" width="49" height="12" font="1">Seth Frietze</text>
<text top="215" left="121" width="88" height="12" font="1">anti-TCF7L2_C48H11</text>
<text top="215" left="339" width="31" height="12" font="1">TCF7L2</text>
<text top="170" left="230" width="37" height="12" font="1">Farnham</text>
<text top="255" left="239" width="108" height="12" font="1">Cell Signaling Technology</text>
<text top="485" left="361" width="27" height="12" font="1">Rabbit</text>
<text top="300" left="395" width="5" height="12" font="1">2</text>
<text top="300" left="215" width="25" height="12" font="1">#2569</text>
<text top="521" left="395" width="19" height="12" font="2">ChIP</text>
<text top="561" left="141" width="30" height="12" font="2">Affinity</text>
<text top="561" left="356" width="50" height="12" font="2">Monoclonal</text>
<text top="419" left="94" width="441" height="12" font="1">TCF7L2, also known as TCF4, is a member of the high mobility group (HMG) DNA binding protein family of </text>
<text top="431" left="94" width="447" height="12" font="1">transcription factors and has a diverse set of biological functions that involve either repressing or activating </text>
<text top="443" left="94" width="211" height="12" font="1">genes involved in Wnt signaling and development.</text>
<text top="599" left="238" width="177" height="12" font="1">http://www.cellsignal.com/products/2569.</text>
<text top="611" left="238" width="20" height="12" font="1">html</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="104" left="125" width="427" height="12" font="1">Anti-TCF7L2 validation. A) Western blot analysis: 25ug of nuclear extracts from HepG2, HelaS3 or MCF7 </text>
<text top="116" left="125" width="420" height="12" font="1">cells were separated by SDS-PAGE and transferred to a nitrocellulose membrane for immunoblotting </text>
<text top="128" left="125" width="418" height="12" font="1">with 1:1,000 anti-TCF7L2 C9B9 antibody in 5% milk/TBST. Two predominant bands corresponding to </text>
<text top="140" left="125" width="169" height="12" font="1">known isoforms of TCF7L2 are detected. </text>
<text top="152" left="125" width="428" height="12" font="1">B) Immunoprecipitation-Western blot analysis of TCF7L2. TCF7L2 was precipitated from 100ug HCT116 </text>
<text top="164" left="125" width="419" height="12" font="1">nuclear extracts using 2 ug of two different anti-TCF7L2 antibodies, C9B9 or C48H11 and 2ug control </text>
<text top="176" left="125" width="417" height="12" font="1">rabbit IgG was used as a control. The eluates of the immunoprecipitation reactions were resolved by </text>
<text top="188" left="125" width="418" height="12" font="1">SDS-PAGE and blotted as in A). Both anti-TCF7L2 antibodies efficiently precipitated the two different </text>
<text top="200" left="125" width="153" height="12" font="1">TCF7L2 isoforms from these extracts.</text>
</page>
<page number="3" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="153" left="130" width="411" height="12" font="1">TCF7L2 ChIP-seq peak overlap comparison. Two different TCF7L2 ChIP-seq datasets were prepared </text>
<text top="165" left="130" width="408" height="12" font="1">from HelaS3 cells either using the anti-TCF7L2 C9B9 antibody or the C48H11 antibody. Peaks were </text>
<text top="177" left="130" width="342" height="12" font="1">called using Solesearch peak calling program and the lists were compared directly.</text>
<text top="695" left="268" width="68" height="12" font="1">Submit by Email</text>
</page>
</pdf2xml>
